Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ann E. Metzloff
Observed name:
Metzloff, Ann
Institution:
University of Pennsylvania
Observed institutions:
Cornell University,
University of Pennsylvania
ORCID:
0000-0003-1422-2387
Observed ORCID:
0000-0003-1422-2387
OpenAlex ID:
A5042556775
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023
·
Margaret M. Billingsley
, Ningqiang Gong
, et al.
·
Small
·
287
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy
2024
·
Ann E. Metzloff
, Marshall S. Padilla
, et al.
·
Advanced Materials
·
79
PDF
In situ PEGylation of CAR T cells alleviates cytokine release syndrome and neurotoxicity
2023
·
Ningqiang Gong
, Xuexiang Han
, et al.
·
Nature Materials
·
74
High-Throughput In Vivo Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route
2024
·
Alex G. Hamilton
, Kelsey L. Swingle
, et al.
·
ACS Nano
·
55
Lipid nanoparticles for engineering next generation CAR T cell immunotherapy
2025
·
Melgious Jin Yan Ang
, Ann E. Metzloff
, et al.
·
Nanoscale Horizons
·
14
PDF
Lighting the way to personalized mRNA immune cell therapies
2022
·
Ann E. Metzloff
, Margaret M. Billingsley
, et al.
·
Science Advances
·
4
PDF
Litmus-Body: A Molecularly Targeted Sensor for Cell-Surface pH Measurements
2020
·
Joe Chin-Hun Kuo
, Marc C. Goudge
, et al.
·
ACS Sensors
·
3
PDF
Engaging student opinions on vaccine development innovation: Experiences from a “Shark Tank” project
2024
·
Jeffrey S. Barrett
, Jeffrey M. Skolnik
, et al.
·
Clinical and Translational Science
·
2
PDF
mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity
2026
·
Ye Zeng
, Junchao Xu
, et al.
·
Proceedings of the National Academy of Sciences
·
1
Engineering mRNA Lipid Nanoparticles to Overcome Barriers to T Cell Cancer Immunotherapy
2026
·
Metzloff, Ann
·
ScholarlyCommons (University of Pennsylvania)
Anti-CD38-Targeted Piperazine-Derived Lipid Nanoparticles Overcome Hepatic Clearance for mRNA Delivery to Multiple Myeloma Cells In Vivo
2025
·
Christian G. Figueroa-Espada
, Hannah C. Geisler
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Author response for "Lipid nanoparticles for engineering next generation CAR T cell immunotherapy"
2025
·
Melgious Jin Yan Ang
, Ann E. Metzloff
, et al.
·
Publons reviews and discussion
Antigen Presenting Cell Mimetic Lipid Nanoparticles for Rapid mRNA CAR T Cell Cancer Immunotherapy (Adv. Mater. 26/2024)
2024
·
Ann E. Metzloff
, Marshall S. Padilla
, et al.
·
Advanced Materials
PDF
Show more works
View as search
Works count:
13
Citation count:
519
H-index:
5
I10-index:
5
Year
Topic
Type
